Verici Dx plc (AIM:VRCI)
0.2000
-0.0050 (-2.44%)
Nov 6, 2026, 4:23 PM GMT
Verici Dx Employees
Verici Dx had 23 employees as of June 30, 2026. The number of employees increased by 5 or 27.78% since the number was reported on December 31, 2025. That makes Verici Dx the 37,897th largest employer in the world and 769th in the United Kingdom.
Employees
23
Change
5
Growth
27.78%
Revenue / Employee
115.41K GBP
Profits / Employee
-258.13K GBP
Market Cap
7.94M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 23 | 5 | 27.78% |
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | -1 | -6.67% |
| Dec 31, 2022 | 15 | 5 | 50.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| GSK plc | 66,841 |
| Haleon | 24,535 |
| Smith & Nephew | 17,000 |
| CelLBxHealth | 114 |
| Aptamer Group | 34 |
| Fusion Antibodies | 27 |
| Palatin Technologies | 25 |
Verici Dx News
- 5 weeks ago - Verici Dx Quarterly report: H1 2026 - Filings
- 4 months ago - Verici Dx Earnings Call Transcript: H2 2025 - Transcripts
- 4 months ago - Verici Dx Annual report: H2 2025 - Filings
- 4 months ago - Verici Dx Annual report: H2 2025 - Filings
- 4 months ago - Verici Dx Slides: H2 2025 - Filings
- 4 months ago - Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test - Business Wire
- 4 months ago - Verici Dx Collaborators to Present Data on Predictive Value of Tutivia™ for Acute Kidney Transplant Rejection at ATC 2026 - Business Wire
- 5 months ago - CORRECTING and REPLACING Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients - Business Wire